Recently, it was reported that BCL11A was amplified in lung squamous cell carcinoma (SCC), and this amplification was significantly more frequent in SCC samples of NSCLC patients without metastases [24]. This evidence concerns the gene BCL11A and squamous cell lung carcinoma.